TrademarkDir
LENTISCREEN
DEAD

Serial Number

78033533

Owner

Oxford BioMedica plc

Attorney

SCOTT K. HAIGHT

Filing Date

Nov 2, 2000

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

LENTISCREEN Trademark

Serial Number: 78033533 • Registration: 3115887

LENTISCREEN is a trademark filed by Oxford BioMedica plc on November 2, 2000. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Oxford BioMedica plc (54 trademarks)

Medawar Centre, Robert Robinson Avenue
Oxford, OX4 4GA , GB

Entity Type: 03

Trademark Details

Filing Date

November 2, 2000

Registration Date

July 18, 2006

Published for Opposition

June 21, 2005

Cancellation Date

February 22, 2013

Goods & Services

GENE THERAPY AND PROPHYLAXIS PRODUCTS, NAMELY, GENE DELIVERY PRODUCTS; ENZYMES AND ENZYME PREPARATIONS FOR USE IN THE MEDICAL INDUSTRY, VECTORS, RETROVIRAL VECTORS AND VECTOR AND RETROVIRAL VECTOR MANUFACTURING PREPARATIONS, ALL FOR USE IN GENE DELIVERY TECHNOLOGY, PRODUCTS FOR USE IN VECTOR PRODUCTION TECHNOLOGIES, NEUROGENOMICS PRODUCTS; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACIDS FOR ASSISTANCE IN DELIVERING GENE THERAPY AND PROPHYLAXIS, NAMELY, GENE DELIVERY SYSTEMS; VACCINES FOR USE IN THE TREATMENT OF DISEASES OF THE BRAIN AND NERVOUS SYSTEM AND MOTOR NEURONE DISEASES, GENE THERAPY AND PROPHYLAXIS AND CHEMICALS AND BIOCHEMICALS FOR USE IN THE MEDICAL INDUSTRY

CHEMICAL AND BIOCHEMICAL PRODUCTS FOR USE IN THE GENE DELIVERY TECHNOLOGY, ENZYMES AND CHEMICALS FOR IN VITRO USE IN LABORATORIES AND FOR ANALYSIS FOR USE IN THE GENE DELIVERY TECHNOLOGY, MICRO-ORGANISMS, DEOXYRIBONUCLEIC ACID SEQUENCES, CLONING VEHICLES AND RECOMBINANT DEOXYRIBONUCLEIC ACID AND VARIATIONS THEREOF, ALL FOR IN VIVO USE IN GENE DELIVERY TECHNOLOGY, AND CATALYSTS FOR GENE DELIVERY TECHNOLOGY

SCIENTIFIC AND MEDICAL RESEARCH AND DEVELOPMENT, GENETIC ENGINEERING SERVICES, BIOTECHNOLOGY SERVICES, NAMELY, BIOTECHNOLOGY RESEARCH IN THE DEVELOPMENT OF THERAPEUTIC PRODUCTS AND VACCINES; MEDICAL RESEARCH AND DEVELOPMENT IN THE FIELD OF VECTOR PRODUCTION TECHNOLOGIES

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 22, 2013 C8..
REGISTERED-PRINCIPAL REGISTER
Jul 18, 2006 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jun 5, 2006 DP1B
NOTICE OF ALLOWANCE CANCELLED
Mar 13, 2006 IUCN
EXPARTE APPEAL TERMINATED
Jan 20, 2006 EXPT
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Sep 14, 2005 ATRQ
NOA MAILED - SOU REQUIRED FROM APPLICANT
Sep 13, 2005 NOAM
TEAS DELETE 1(B) BASIS RECEIVED
Sep 8, 2005 D1BR
PUBLISHED FOR OPPOSITION
Jun 21, 2005 PUBO
NOTICE OF PUBLICATION
Jun 1, 2005 NPUB
ASSIGNED TO EXAMINER
Mar 7, 2005 DOCK
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 1, 2005 PREV
ASSIGNED TO LIE
Feb 28, 2005 ALIE
ASSIGNED TO LIE
Jan 7, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2005 CNSA
CASE FILE IN TICRS
Jul 13, 2004 CFIT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jun 30, 2004 JURT
PAPER RECEIVED
Jun 24, 2004 MAIL
PAPER RECEIVED
Apr 22, 2004 MAIL
CONTINUATION OF FINAL REFUSAL MAILED
Apr 15, 2004 CNCF
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Mar 8, 2003 JURT
PAPER RECEIVED
Feb 21, 2003 MAIL
CONTINUATION OF FINAL REFUSAL MAILED
Aug 14, 2002 CNCF
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jun 10, 2002 JURT
EX PARTE APPEAL-INSTITUTED
Jun 10, 2002 EXPI
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2002 CRFA
PAPER RECEIVED
May 6, 2002 MAIL
FINAL REFUSAL MAILED
Feb 14, 2002 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2001 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 19, 2001 CRFA
NON-FINAL ACTION MAILED
Apr 19, 2001 CNRT
ASSIGNED TO EXAMINER
Mar 28, 2001 DOCK

Related Trademarks

More from this Owner

OXB

OXB

OXB

OXB

OXB

OXB

OXB logo

OXB

OXB logo

OXB

OXB logo

OXB